Standard
Atrial Natriuretic Peptide (ANP) in early pregnancy is associated with development of preeclampsia in type 1 diabetes. / Nielsen, Lene Ringholm; Pedersen-Bjergaard, Ulrik; Thorsteinsson, Birger; Boomsma, Frans; Damm, Peter; Mathiesen, Elisabeth R.
I:
Diabetes Research and Clinical Practice, Bind 93, Nr. 3, 2011, s. e106-9.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Nielsen, LR, Pedersen-Bjergaard, U, Thorsteinsson, B, Boomsma, F
, Damm, P & Mathiesen, ER 2011, '
Atrial Natriuretic Peptide (ANP) in early pregnancy is associated with development of preeclampsia in type 1 diabetes',
Diabetes Research and Clinical Practice, bind 93, nr. 3, s. e106-9.
https://doi.org/10.1016/j.diabres.2011.06.007
APA
Nielsen, L. R., Pedersen-Bjergaard, U., Thorsteinsson, B., Boomsma, F.
, Damm, P., & Mathiesen, E. R. (2011).
Atrial Natriuretic Peptide (ANP) in early pregnancy is associated with development of preeclampsia in type 1 diabetes.
Diabetes Research and Clinical Practice,
93(3), e106-9.
https://doi.org/10.1016/j.diabres.2011.06.007
Vancouver
Nielsen LR, Pedersen-Bjergaard U, Thorsteinsson B, Boomsma F
, Damm P, Mathiesen ER.
Atrial Natriuretic Peptide (ANP) in early pregnancy is associated with development of preeclampsia in type 1 diabetes.
Diabetes Research and Clinical Practice. 2011;93(3):e106-9.
https://doi.org/10.1016/j.diabres.2011.06.007
Author
Nielsen, Lene Ringholm ; Pedersen-Bjergaard, Ulrik ; Thorsteinsson, Birger ; Boomsma, Frans ; Damm, Peter ; Mathiesen, Elisabeth R. / Atrial Natriuretic Peptide (ANP) in early pregnancy is associated with development of preeclampsia in type 1 diabetes. I: Diabetes Research and Clinical Practice. 2011 ; Bind 93, Nr. 3. s. e106-9.
Bibtex
@article{297ceb5b75434be7924332d43d90f878,
title = "Atrial Natriuretic Peptide (ANP) in early pregnancy is associated with development of preeclampsia in type 1 diabetes",
abstract = "The vasoactive markers of cardiac overload Atrial Natriuretic Peptide (ANP) and Brain Natriuretic Peptide (BNP) are elevated in preeclampsia. This study documents higher ANP concentrations as early as at 9 weeks in type 1 diabetic women subsequently developing preeclampsia suggesting that preeclampsia is associated with cardiovascular changes in early pregnancy.",
author = "Nielsen, {Lene Ringholm} and Ulrik Pedersen-Bjergaard and Birger Thorsteinsson and Frans Boomsma and Peter Damm and Mathiesen, {Elisabeth R}",
note = "Copyright {\textcopyright} 2011 Elsevier Ireland Ltd. All rights reserved.",
year = "2011",
doi = "http://dx.doi.org/10.1016/j.diabres.2011.06.007",
language = "English",
volume = "93",
pages = "e106--9",
journal = "Diabetes Research and Clinical Practice",
issn = "0168-8227",
publisher = "Elsevier Ireland Ltd",
number = "3",
}
RIS
TY - JOUR
T1 - Atrial Natriuretic Peptide (ANP) in early pregnancy is associated with development of preeclampsia in type 1 diabetes
AU - Nielsen, Lene Ringholm
AU - Pedersen-Bjergaard, Ulrik
AU - Thorsteinsson, Birger
AU - Boomsma, Frans
AU - Damm, Peter
AU - Mathiesen, Elisabeth R
N1 - Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
PY - 2011
Y1 - 2011
N2 - The vasoactive markers of cardiac overload Atrial Natriuretic Peptide (ANP) and Brain Natriuretic Peptide (BNP) are elevated in preeclampsia. This study documents higher ANP concentrations as early as at 9 weeks in type 1 diabetic women subsequently developing preeclampsia suggesting that preeclampsia is associated with cardiovascular changes in early pregnancy.
AB - The vasoactive markers of cardiac overload Atrial Natriuretic Peptide (ANP) and Brain Natriuretic Peptide (BNP) are elevated in preeclampsia. This study documents higher ANP concentrations as early as at 9 weeks in type 1 diabetic women subsequently developing preeclampsia suggesting that preeclampsia is associated with cardiovascular changes in early pregnancy.
U2 - http://dx.doi.org/10.1016/j.diabres.2011.06.007
DO - http://dx.doi.org/10.1016/j.diabres.2011.06.007
M3 - Journal article
VL - 93
SP - e106-9
JO - Diabetes Research and Clinical Practice
JF - Diabetes Research and Clinical Practice
SN - 0168-8227
IS - 3
ER -